Have Student Loans between 10,000 and 20,000, 2027488001. If you have Student Loans totaling more than 20,000, 2027488002 is the number. If you have no Student Loan Debt, 2027488003. You can catch up with us on social media. On twitter it is cspanwj. On facebook it as facebook. Com cspan. Beginning our program where we left off yesterday on the idea of the Student Loan Debt prices crisis, more than 45 million americans have Student Loan Debt. The total debt in 2018 was 1. 5 trillion and it increased since then. 2 million american borrowers have defaulted on their loans. Because of those defaults, the jected taxpayer loss is the average Student Loan Debt amount, some 37,000 for those who take out Student Loan Debts. It comes out to about an average of 293 a month. Those numbers from the Federal Reserve bank of new york. Having this conversation a day after senator Bernie Sanders announced his proposal to eliminate student dont Student Loan Debt. Here is senator sanders from yesterday. [
Congress. Former special Counsel Robert Mueller is set to appear before two committees of congress. The House Judiciary Committee and the House Intelligence Committee on wednesday, july 17th, at 9 00 a. M. Eastern. Hell testify in open session about his report into russian interference in the 2016 election. Watch live coverage on cspan3 j online at cspan. Org or listen with the free cspan radio app. The house energy and Commerce Sub Committee on health heard from officials from two pharmaceutical trade associations. They testified alongside other policy experts. Good morning, everyone. The Sub Committee on health will now come to order. The chair now recognizes for five minutes for an opening statement. Last week our Sub Committee held a hearing to essentially follow the money in the drug supply chain. We came away with much valuable information, but we also found there are many secrets. Secret decisions about how drugs are priced. Secret deals between Drug Companies and the pbms and s
Committee chair chuck grassley, former fda commissioner Scott Gottlieb and others. [ applause ] hi, everyone. Thank you for coming. And thanks to pfizer for sponsoring the event. Just to reiterate, if youre into hash tags, go ahead and use axios 360 and we can have fun on the social networks together. And if youre also inclined, go to signup. Axios. Com to get our news letters, especially vitals, written by my colleague, Caitlyn Owens. We try to keep things short and light. And real quick, logistic, if youve never been to one of our events before, we try to keep things short and sweet. Four segments of interviews. We want you leaving here feeling smarter about what we talked about. And this in particular is about drug pricing in america, which obviously will continue to be an issue going into 2020. So with that in mind, id like to welcome our first guest, senator chuck grassley. [ applause ] good to be with you, bob. Thanks for coming. All right. I think its only its a good place to st
Ned sharpless. Washington post. This is about 1 hour and 40 minutes. Good morning. I am lori mcginley. I am a help than science reporter here at the washington post. I am delighted to be joined this morning by acting fda commissioner, dr. Ned sharpless. Thank you for being with us. Good morning. Thank for having a. Dr. Sharpless has been on the job a little over two months of the fda. Was previously the director of the National Cancer institute. Dr. Sharpless, let me start by asking, you been there a whole two months now. So, how do you hope to make your mark on the fda . I think maybe it is relevant to talk about my background that brought me to my job a little bit. I a cancer doctor. At some point, transition from taking my patients more in the lab from running in Academic Research lab cancer. I felt like we were, at that time, the progress of cancer was really slow and it was frustrating. From doing the same things over and over with patience. We were helping them. To the degree tha
Good morning. I am lori mcginley. I am a help than science reporter here at the washington post. I am delighted to be joined this morning by acting fda commissioner, dr. Ned sharpless. Thank you for being with us. Good morning. Thank for having a. Dr. Sharpless has been on the job a little over two months of the fda. Was previously the director of the National Cancer institute. Dr. Sharpless, let me start by asking, you been there a whole two months now. So, how do you hope to make your mark on the fda . I think maybe it is relevant to talk about my background that brought me to my job a little bit. I a cancer doctor. At some point, transition from taking my patients more in the lab from running in Academic Research lab cancer. I felt like we were, at that time, the progress of cancer was really slow and it was frustrating. From doing the same things over and over with patience. We were helping them. To the degree that i would have liked. Beyond became a researcher. And at some point d